These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 2475275

  • 41. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J, Hugli TE, Smedegård G.
    J Immunol; 1985 Feb; 134(2):1115-9. PubMed ID: 3871207
    [Abstract] [Full Text] [Related]

  • 42. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
    Miadonna A, Leggieri E, Tedeschi A, Cottini M, Invernizzi F, Froldi M, Zanussi C.
    Int Arch Allergy Appl Immunol; 1985 Feb; 76(2):120-5. PubMed ID: 3967939
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J.
    Enzyme; 1986 Feb; 36(1-2):150-63. PubMed ID: 3491754
    [Abstract] [Full Text] [Related]

  • 45. Effects of complement activation in the isolated heart. Role of the terminal complement components.
    Homeister JW, Satoh P, Lucchesi BR.
    Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389
    [Abstract] [Full Text] [Related]

  • 46. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

  • 47. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C, Damerau B, Lemgo E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 15; 295(1):71-6. PubMed ID: 1004644
    [Abstract] [Full Text] [Related]

  • 48. Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis.
    Hopkins P, Belmont HM, Buyon J, Philips M, Weissmann G, Abramson SB.
    Arthritis Rheum; 1988 May 15; 31(5):632-41. PubMed ID: 3259882
    [Abstract] [Full Text] [Related]

  • 49. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE, Cheung AK, Henderson LW.
    Kidney Int; 1983 Dec 15; 24(6):764-9. PubMed ID: 6609269
    [Abstract] [Full Text] [Related]

  • 50. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L, Bengtson A, Heideman M.
    J Surg Res; 1989 Aug 15; 47(2):138-43. PubMed ID: 2787873
    [Abstract] [Full Text] [Related]

  • 51. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW.
    N Engl J Med; 1981 Feb 26; 304(9):497-503. PubMed ID: 7453783
    [Abstract] [Full Text] [Related]

  • 52. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.
    Chenoweth DE.
    Contrib Nephrol; 1987 Feb 26; 59():51-71. PubMed ID: 3327650
    [Abstract] [Full Text] [Related]

  • 53. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul 26; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 54. The active site of human C4a anaphylatoxin.
    Hugli TE, Kawahara MS, Unson CG, Molinar-Rode R, Erickson BW.
    Mol Immunol; 1983 Jun 26; 20(6):637-45. PubMed ID: 6603573
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C, Hugli TE.
    Proc Natl Acad Sci U S A; 1981 Mar 26; 78(3):1833-7. PubMed ID: 6940191
    [Abstract] [Full Text] [Related]

  • 57. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients.
    Suzuki Y, Uchida J, Tsuji H, Kuzuhara K, Hara S, Nihei H, Ogura Y, Otsubo O, Mimura N.
    Tohoku J Exp Med; 1987 May 26; 152(1):35-45. PubMed ID: 3497472
    [Abstract] [Full Text] [Related]

  • 58. Complement activation produced by biomaterials.
    Chenoweth DE.
    Artif Organs; 1988 Dec 26; 12(6):508-10. PubMed ID: 3265053
    [Abstract] [Full Text] [Related]

  • 59. Complement activation during liver transplantation.
    Tomasdottir H, Henriksson BA, Bengtson JP, Bengtsson A, Stenqvist O, Persson H.
    Transplantation; 1993 Apr 26; 55(4):799-802. PubMed ID: 8475554
    [Abstract] [Full Text] [Related]

  • 60. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK, Chenoweth DE, Otsuka D, Henderson LW.
    Kidney Int; 1986 Jul 26; 30(1):74-80. PubMed ID: 3489123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.